The Case Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1826-01-01

Employees: 5K

Market Cap: -

Website: http://www.case.edu/cancer

Clinical Trials

Mycobiome Supporting Diet to Reduce GI Toxicity Associated With ASCT

Not Applicable

Withdrawn

Conditions: Autologous Transplant
Myeloma

Interventions: Behavioral: Mycobiome Supporting Diet

First Posted Date: 2020-12-28

Last Posted Date: 2024-04-26

Lead Sponsor: Case Comprehensive Cancer Center

Registration Number: NCT04685525

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

CPX-351 as a Novel Approach for the Treatment of Older Patients With AML and MDS

Phase 2

Active, not recruiting

Conditions: Myelodysplastic Syndromes
Refractory Acute Myeloid Leukemia
Relapsed Acute Myelomonocytic Leukemia

Interventions: Drug: CPX-351

First Posted Date: 2020-12-16

Last Posted Date: 2025-01-03

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 13

Registration Number: NCT04668885

Locations: 🇺🇸
Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Intervention for Caregivers of Patients Who Have Recently Undergone HSCT

Not Applicable

Withdrawn

Conditions: Caregiver Anxiety
Caregiver Health Related QOL
Caregiver Distress

Interventions: Behavioral: Psycho-educational intervention

First Posted Date: 2020-11-20

Last Posted Date: 2021-05-25

Lead Sponsor: Case Comprehensive Cancer Center

Registration Number: NCT04639700

Captopril Use on the Degree of Marrow Fibrosis in Bone Marrow Fibrosis/Myeloproliferative Neoplasms

Phase 1

Withdrawn

Conditions: Bone Marrow Fibrosis
Myeloproliferative Neoplasm

Interventions: Drug: Captopril

First Posted Date: 2020-11-16

Last Posted Date: 2023-10-11

Lead Sponsor: Case Comprehensive Cancer Center

Registration Number: NCT04629651

Locations: 🇺🇸
Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors

Recruiting

Conditions: Adenocarcinoma of the Colon
Stage III Colorectal Cancer
Stage I Colorectal Cancer
Stage II Colorectal Cancer
Adenocarcinoma of the Rectum

First Posted Date: 2020-11-12

Last Posted Date: 2024-07-29

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 50

Registration Number: NCT04624555

Locations: 🇺🇸
University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer

Phase 1

Active, not recruiting

Conditions: Renal Cell Cancer
Cutaneous Malignant Melanoma
Urothelial Cancer of Renal Pelvis

Interventions: Radiation: Low Dose Rate Brachytherapy (LDR)
Drug: Standard-of-Care Immunotherapy

First Posted Date: 2020-11-09

Last Posted Date: 2025-05-14

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 5

Registration Number: NCT04620603

Locations: 🇺🇸
Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Exercise Therapy and Radiation Therapy (EXERT) for Metastatic Prostate Cancer

Not Applicable

Recruiting

Conditions: Metastatic Prostate Cancer

Interventions: Behavioral: Exercise therapy

First Posted Date: 2020-09-21

Last Posted Date: 2025-02-04

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 80

Registration Number: NCT04556045

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue

Not Applicable

Active, not recruiting

Conditions: Glioblastoma

Interventions: Device: NICO Myriad and Tissue Preservation System (TPS)

First Posted Date: 2020-09-10

Last Posted Date: 2025-01-07

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 18

Registration Number: NCT04545177

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Assessing the Benefit of Art & Music Therapy on Quality of Life in Patients With Breast Cancer

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Behavioral: Art Therapy
Behavioral: Music Therapy

First Posted Date: 2020-07-30

Last Posted Date: 2024-12-18

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 72

Registration Number: NCT04493034

Locations: 🇺🇸
Cleveland Clinic Florida Weston, Case Comprehensive Cancer Center, Weston, Florida, United States

Liquid Biopsy to Reduce Time to Treatment for Advanced Nonsquamous NSCLC Diagnosed at Outside Sites

Not Applicable

Terminated

Conditions: Non Small Cell Lung Cancer

Interventions: Diagnostic Test: Liquid biopsy

First Posted Date: 2020-07-17

Last Posted Date: 2025-02-05

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 26

Registration Number: NCT04474613

Locations: 🇺🇸
Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Home Terms & Conditions Privacy Policy